Skip to content

Effects of different doses of lidocaine combined with butorphanol on analgesia and gastrointestinal function after laparoscopic total hysterectomy

Effects of different doses of lidocaine combined with butorphanol on analgesia and gastrointestinal function after laparoscopic total hysterectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111183
Enrollment
Unknown
Registered
2025-10-27
Start date
2025-11-02
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine fibroids

Interventions

Butorphanol group (B group):0.9% Normal Saline
Low-dose lidocaine group (D group):1 mg/kg/h lidocaine analgesic pump infusion
High-dose lidocaine (G group):1.5mg/kg/h lidocaine analgesia pump infusion

Sponsors

Chengdu Wenjiang District People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Age: 18-80 years old; 2. 18 < BMI < 30 kg/m^2; 3. American Society of Anesthesiologists (ASA) class I to III; 4. Exclude patients with severe bradycardia, arrhythmias, or other cardiac dysfunctions; 5. Patients scheduled for elective laparoscopic total hysterectomy.

Exclusion criteria

Exclusion criteria: 1. Patients with II/III degree atrioventricular block or those who develop severe bradycardia during the perioperative period requiring urgent management, 2. Critically ill patients, including those with poorly controlled blood pressure: systolic BP >= 180 mmHg and/or diastolic BP >= 105 mmHg, severe hepatic and renal dysfunction, etc.; 3. Pregnant or breastfeeding women; 4. Patients allergic to amide-type local anesthetics; 5. Surgery duration > 6 hours; 6. Patients who refuse to sign the consent form; 7. Patients with severe preoperative anemia or requiring blood transfusion during surgery; 8. Patients with liver dysfunction (Child-Pugh score C); 9. Any other reasons deemed by the investigator as making the patient unsuitable for participation in the study.

Design outcomes

Primary

MeasureTime frame
Postoperative resting and exercise visual scores;

Secondary

MeasureTime frame
Number of effective presses, number of rescue analgesia administrations, and total dose;Restore Quality QoR-15 Score;Time of first urination/defecation;Incidence of nausea and vomiting;Time of first ambulation;Length of hospital stay;

Countries

China

Contacts

Public ContactHe Danyang

Chengdu Wenjiang District People’s Hospital

657643420@qq.com+86 813 754 0463

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026